📰 Package Leaflet News
Page 7 - Package Leaflet News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Package Leaflet. Real-time updates on events, politics, business and more.
February 3, 2022
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
January 12, 2022
GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- Novavax, Inc. , a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK... | January 12, 2022
January 12, 2022
GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing...
January 12, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
January 10, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
January 10, 2022
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
November 25, 2021
NEW YORK and MAINZ, Germany, November 25, 2021-Pfizer Inc.(Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)
November 25, 2021
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
October 26, 2021
Authorization granted for particularly vulnerable individuals 12 years of age and older Swissmedic also authorized a third dose for individuals 12 years of age and older with a weakened immune system
October 25, 2021
Recommendation granted for individuals 18 years of age and older Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that